Animal Antibiotics and Antimicrobials Market is Expected to Reach $5.6 Billion | MarketsandMarkets.

Chicago, July 20, 2023 (GLOBE NEWSWIRE) -- The animal antibiotics and antimicrobials industry is poised for significant changes and advancements in the near future as concerns over antimicrobial resistance and the need for sustainable animal agriculture intensify. With increasing global demand for animal protein and the potential public health risks associated with antibiotic misuse in animal production, there is a growing focus on developing alternatives and adopting responsible antimicrobial use practices. The industry is witnessing a shift towards the development and implementation of innovative solutions, including vaccines, probiotics, prebiotics, and other biosecurity measures, to reduce the reliance on antibiotics. Regulatory measures are also being implemented to enforce stricter controls and promote responsible antibiotic use in livestock and aquaculture production. Additionally, advancements in precision farming, diagnostics, and digital technologies are enabling better monitoring of animal health, early disease detection, and targeted antimicrobial interventions. The near future will likely see a more integrated and holistic approach to animal health management, emphasizing prevention, improved biosecurity, and sustainable practices. This transition will not only address the challenge of antimicrobial resistance but also ensure the continued production of safe and healthy animal products while safeguarding public health.

Animal Antibiotics and Antimicrobials market in terms of revenue was estimated to be worth $4.7 Billion in 2021 and is poised to reach $5.6 Billion by 2026, growing at a CAGR of 3.6% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming years.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353

Animal Antibiotics and Antimicrobials Market Scope:

Report Coverage	Details
Market Revenue in 2021	$4.7 Billion
Estimated Value by 2026	$5.6 Billion
Growth Rate	Poised to grow at a CAGR of 3.6%
Market Size Available for	2019-2026
Forecast Period	2021–2026
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Type of product, Mode of Delivery, Animal Type and Region
Geographies Covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunities	Growth in the companion animal population
Key Market Drivers	Rising demand for animal-derived food products

Animal Antibiotics and Antimicrobials market major players covered in the report, such as:

• Boehringer Ingelheim (Germany)
• Zoetis Inc. (US)
• Elanco Animal Health (US)
• Merck & Co. Inc. (US)
• Phibro Animal Health (US)
• Virbac (France)
• Vetoquinol SA (France)
• HIPRA (Spain)
• Ceva Santé Animale (France)
• Dechra Pharmaceuticals Plc (UK)
• Kyoritsu Seiyaku (Japan)
• Tianjin Ringpu (China)
• China Animal Husbandry (China)
• Endovac Animal Health (US)
• Zydus (India)
• Indian Immunologicals Pvt. Ltd. (India)
• UCBVET (US)
• American Reagent Inc. (US)
• Neogen Corporation (US)
• Huvepharma Inc. (US)
• Ayurvet (India)
• Ashish Life Science (India)
• Inovet (Belgium)
• Lutim Pharma (India)
• and ECO Animal Health (US)
• and Among Others

Buy Animal Antibiotics and Antimicrobials Industry Report (152 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=25161353

The study categorizes the animal antimicrobials and antibiotics market based on By Type of Product, Mode of Delivery, and Animal Type at the regional and global level.

By Type of Product

• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides
• Lincosamides
• Fluoroquinolones
• Cephalosporins
• Other Antimicrobials and Antibiotics

By Mode of Delivery

• Premixes
• Oral Powder
• Oral Solution
• Injection
• Others

By Animal Type

• Food-Producing Animals              
  • Cattle                   
  • Pigs                       
  • Poultry                
  • Sheep and Goats             
  • Other Food-producing Animals
• Companion Animals       
  • Dogs                     
  • Cats                      
  • Horses                 
  • Other Companion Animals

Animal Antibiotics and Antimicrobials Market, by region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
  • Brazil
  • RoLATAM
• Middle East and Africa (MEA)

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=25161353

The key stakeholders in the Animal Antibiotics and Antimicrobials market include:

• Pharmaceutical Companies: Pharmaceutical companies play a crucial role in the development, manufacturing, and distribution of animal antibiotics and antimicrobials. They invest in research and development to create new veterinary drugs, ensure their safety and efficacy, and obtain regulatory approvals.
• Farmers and Livestock Producers: Farmers and livestock producers are significant stakeholders in the animal antibiotics and antimicrobials market as they are the end-users of these products. They utilize antibiotics and antimicrobials to maintain animal health, prevent and treat infections, and promote growth and productivity in livestock and aquaculture operations.
• Veterinary Professionals: Veterinarians and veterinary professionals are essential stakeholders who prescribe, administer, and oversee the use of antibiotics and antimicrobials in animals. They play a vital role in ensuring responsible use, proper dosing, and the prevention of antibiotic resistance through diagnostic testing and treatment protocols.
• Regulatory Authorities: Regulatory authorities, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, have a significant impact on the animal antibiotics and antimicrobials market. They set guidelines, standards, and regulations for the approval, distribution, and use of these products, with a focus on promoting responsible use and minimizing the risk of antimicrobial resistance.
• Animal Health Organizations: Organizations dedicated to animal health, welfare, and the promotion of responsible antimicrobial use are important stakeholders. They provide guidance, education, and advocacy to farmers, veterinarians, and the public, promoting best practices and raising awareness about the importance of judicious antibiotic use in animals.
• Research Institutions and Academia: Research institutions and academic organizations contribute to the animal antibiotics and antimicrobials market by conducting studies, clinical trials, and research to understand the efficacy, safety, and potential alternatives to antibiotics. Their work drives innovation and helps develop new strategies for disease prevention and treatment in animals.
• Consumers and Public Health Organizations: Consumers and public health organizations are increasingly concerned about the use of antibiotics in animal production and its impact on human health. They advocate for responsible antibiotic use, sustainable farming practices, and the reduction of antibiotic-resistant infections, influencing market trends and driving demand for alternatives and transparency in the animal antibiotics and antimicrobials market.

Frequently Asked Questions (FAQs) of Animal Antibiotics and Antimicrobials Market:

Q1. What is the total market value of Animal Antibiotics and Antimicrobials Market report?

Q2. Which are the top companies holding the market share in Animal Antibiotics and Antimicrobials Market?

Q3. Which are the largest regions for this Market?

Q4. What is the leading technology of Animal Antibiotics and Antimicrobials Market?

Q5. What are the major drivers for this specific Market?

Q6. What are the upcoming key trends in the Animal Antibiotics and Antimicrobials Market report?

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=25161353

Recent Developments:

• In 2020, Zoetis (US) acquired entered into an agreement with Trianni Inc. (US) to develop transgenic monoclonal antibody platforms for the discovery of new veterinary treatmentsThe acquisition of
• In 2020, Zoetis (US) received FDA approval for Marboquin
• In 2019, Elanco (US) collaborated with AgBiome to develop nutritional health products for porcine animals.
• In 2019, Elanco Animal Health (US) Announced the acquisition of Bayer’s Animal Health Business, thereby expanding its own companion animal business and portfolio mix by creating a balance between its food animal and companion animal segments
• In 2019, Boehringer Ingelheim (Germany) acquired Sanofi’s Animal Health business (Merial), and Sanofi took over Boehringer Ingelheim’s Consumer Healthcare (CHC) business. The acquisition of Merial made BI the world’s second-largest animal health company

Related Reports:

Animal Parasiticides Market

Veterinary Vaccines Market

Animal Growth Promoters Market

Veterinary Imaging Market

Asia-Pacific Animal Health Market

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/animal-antimicrobials-antibiotics-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/animal-antimicrobials-antibiotics.asp

            About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com